Narcolepsy Drug Market Projected to Grow at a Steady Pace During 2020–2030
Narcolepsy Drug Market is valued around USD 2.65 Billion
in 2019 and expected to reach USD 6.48 Billion by 2030 with the CAGR of 8.4%
over the forecast period.
Narcolepsy drugs are used
for the treatment of neurological disorder named narcolepsy and also used for
the treatment of sleep apnea. Narcolepsy is a condition which hampers the
sleeping patterns and sleep quality of an individual with further advancement
includes lack of muscle strength, hallucination and others. All the symptoms
can be fatal in a long term with undiagnosed nature of the disease for a long
period of time owing to the low prevalence rate and lack of proper knowledge
about it. Due to the undiagnosed nature of disease it is also classified into
orphan disease.
Global Narcolepsy Drug Market
report is segmented on the basis of disease type, diagnosis, drug type and by
regional. Based upon disease type, the narcolepsy drug market is fragmented
into narcolepsy type I and narcolepsy type II. On the basis of diagnosis, the
market is categorized into Polysomnogram, and Multiple Sleep Latency Test.
Based on drug type, the market is fragmented into Central Nervous System
Stimulants, Tricyclic Antidepressants, Sodium Oxybate, Selective Serotonin Reuptake
Inhibitor, and Others. The regional bifurcation of countries includes North
America, Europe, Asia-Pacific, and RoW which are further segmented into major
countries such as U.S., UK, France, and others.
The narcolepsy drugs market
is mainly driven by the changing lifestyle among young individuals with
increased consumption of alcohol, tobacco, smoking and other which disturbs the
sleeping patterns. Moreover, rising stress level and amplification in public
awareness about various sleep disorders are also act as the major driving
factors. Moreover, increase in government initiatives to create awareness about
orphan disease as well as life threatening symptoms are also likely to promote
market growth. However, lack of awareness, diagnosis & treatment
among people are expected to inhibit the market growth. On the other hand,
increase in research & development activities along with FDA approvals are
likely to create new avenues in the market.
Download sample copy of
this report at https://www.nextmsc.com/Narcolepsy-Drug-Market/request-sample
The developed regions such
as North America and Europe are expected to hold the major market share owing
to the presence of major market players in the region together with increasing
FDA approvals to the new & advanced drugs as well as presence of well-established
healthcare facilities & infrastructure. Moreover, Asia Pacific is expected
to dominate the narcolepsy drug market in terms of growth rate owing to the developing
healthcare facilities. In addition, improved public awareness about sleep
disorder along with surge in disposable income is also expected to fuel the
market growth.
The major market players
profiled in the narcolepsy drug market includes Addrenex Pharmaceuticals, Arena
Pharmaceuticals, Shire Plc, Teva Pharmaceutical Industries Ltd., Bioprojet,
Ligand Pharmaceuticals, Jazz Pharmaceuticals Plc., and Graymark Healthcare, Inc
among others.
About Us:
Next Move Strategy Consulting is an
independent and trusted third-platform market intelligence provider, committed
to deliver high quality, market research reports that help multinational
companies to triumph over their competitions and increase industry footprint by
capturing greater market share. Our research model is a unique collaboration of
primary research, secondary research, data mining and data analytics.
We have been servicing over 1000 customers
globally that includes 90% of the Fortune 500 companies over a decade. Our
analysts are constantly tracking various high growth markets and identifying
hidden opportunities in each sector or the industry. We provide one of the industry’s
best quality syndicate as well as custom research reports across 10 different
industry verticals. We are committed to deliver high quality research solutions
in accordance to your business needs. Our industry standard delivery solutions
that range from the pre consultation to after-sales services provide an
excellent client experience and ensure right strategic decision making for
businesses.
Contact
US:
Joseph Lawrence (Head - Client Engagement &
Servicing)
Joseph@nextmsc.com
Comments
Post a Comment